Robert Stolper partners with biopharmaceutical clients to develop and commercialize novel therapeutics by building an understanding of and strategy to demonstrate value in the market place. He brings more than 15 years of experience working with clients to develop innovative solutions around clinical development, commercial strategy, life cycle management, evidence optimization, and market access.
Mr. Stolper’s work spans all major therapeutic areas as well as rare diseases, and both major and emerging global markets. He serves as an advisor to the Masters of Science in Management Studies (MSMS) program at Boston University’s Questrom School of Business, where he has lectured on topics including the application of primary research to strategy development and product life cycle management for pharmaceuticals.
Mr. Stolper received his A.B. in Biochemical Sciences, with honors, from Harvard University.